U.S. Markets close in 1 hr 43 mins

SciClone Pharmaceuticals, Inc. (SCLN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.100.00 (0.00%)
As of 2:16PM EDT. Market open.
People also watch
SPPIPGNXRIGLRGENVICL
  • D
    Dirk Diggler
    Dirk Diggler
    CapitalCube thinks SciClone has a relative valuation of UNDERVALUED. So again, $11.18/share apparently isn't a fair offer. Vote NO.
  • S
    Sophia
    Sophia
    Who says SCLN isn't poised for potentially massive upward movement? I started receiving notifications from awe.some_sto-cks the other week and so far they have presented interesting new trade ideas.
  • D
    Dirk Diggler
    Dirk Diggler
    Immunotherapy is huge right now. Gilead acquired cancer-immunotherapy company Kite for $12B, a 29.4 percent premium over Friday close. What do we get? A measly 11% premium. Vote NO! China has more than 4 times the population of the U.S. and imo, Zadaxin sales have nowhere to go but up.
  • g
    greg
    greg
    Got my proxy. FWIW....vote NO!!
  • D
    Dirk Diggler
    Dirk Diggler
    There's the potential Class Action Lawsuit. Given that a large number of shares have already been tendered on the open market (a third of mine included), actually below $11.18, sweetening the deal to avoid litigation is the most cost effective move. Just do it!
  • g
    greg
    greg
    Don't get me wrong, I have about 0% confidence that it will do any good, but FWIW I see that there are 3 lawsuits filed against SCLN regarding the sale. IMHO every time another great earnings report comes out, even with Blobel's self serving attempts to throw cold water on the news, their credibility goes lower and lower...if that's even possible...as SCLN's cash goes higher and higher.
  • S
    Samantha
    Samantha
    The upside potential for SCLN just got a whole lot more interesting. check out Awe.Som.e.Sto-cks., its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • b
    bob
    bob
    May relate to Dirks post 2months ago.
    the headline number of 11.18 was misleading.
    Those that know, not us, knew it was higher.
    Perhaps its 11.60 or something.

    Wild, wild thought. there may have been some
    study result that makes SCLN more valuable...
    and may allow for a higher price. But that idea
    is most likely pure fantasy.

    I'm not overly excited Ive watched this stock
    drop 50c a hundred times. with no explanation.
  • T
    Timothy Blackbread
    Timothy Blackbread
    Anyone knows what's going on? A lot of shares changing hands above the offering price today.
  • Z
    Zo
    Zo
    scln >> LNTH
  • g
    greg
    greg
    When are they gonna cut to the chase and have a vote on this so called "deal", so we can move on? This money isn't working for us while we wait.
  • g
    greg
    greg
    There is no joy in Mudville...FWIW I'm voting NO. If the analyst estimates for 2017 and 2018 earnings are anywhere near accurate, this is much more than an $11 stock. But it's probably a done deal, so at my age, I'll just take my money and put it into something that generates some dividends or interest.
  • D
    Dirk Diggler
    Dirk Diggler
    $605M purchase price divided by 51.732M trading shares equals $11.69 per share, not $11.18 per share. What gives?! Who owns the other 2.382M shares and why are they a part of this transaction?
  • D
    Dirk Diggler
    Dirk Diggler
    Confirmed: Shares outstanding is 51.73M. 51.73M times $11.18 per share is $578.34M. If the purchase price is $605M, where's the other $26.66M going?! Why isn't this an $11.69 per share acquisition?
  • D
    Dirk Diggler
    Dirk Diggler
    One other note: SciClone has $141M in cash. All the more reason to demand $11.69 per share, at a minimum. Keep the lawyers out of this. Do the right thing.
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    SCLN is up 7.92% to 10.90
  • g
    greg
    greg
    So, will someone continue to hold a tight $10 lid on this today?
  • T
    Timothy Blackbread
    Timothy Blackbread
    Ok, could be better, could be worse. I should have sold more at $13 but still tripled my money from 2013. Enjoy your retirement, Friedhelm.
  • J
    John
    John

    The best way to escape from a difficult problem is to solve it.http://dataunion.tistory.com/8682

    SciClone Pharmaceuticals NASDAQ $SCLN Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.7 In other words, the correlation coefficient of the other stoc
    dataunion.tistory.com
  • j
    j
    j
    summer catalysts : neucardin? newer partnership with established approved drug in china? renewed buyout interest?
    any others?